Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Guiso

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Expert Review of Vaccines|July 19, 2014
Other Bordetellas, lessons for and from pertussis vaccinesNicole Guiso, Nicolas Hegerle
Emerging Infectious Diseases|April 30, 2013
Virulence of pertactin-negative Bordetella pertussis isolates from infants, FranceHélène Bodilis, Nicole Guiso
Future Microbiology|November 9, 2013
Epidemiology of whooping cough & typing of Bordetella pertussisNicolas Hegerle, Nicole Guiso
Advances in Experimental Medicine and Biology|July 26, 2019
Pertussis in Low and Medium Income Countries: A Pragmatic ApproachNicole Guiso, Fabien Taieb
Expert Review of Vaccines|June 24, 2014
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccinesNicolas Hegerle, Nicole Guiso
Human Vaccines|March 11, 2011
The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010Nicole Guiso, Johannes Liese, Stanley Plotkin
Evolution, Medicine, and Public Health|August 29, 2022
Can vaccines control bacterial virulence and pathogenicity? <i>Bordetella pertussis</i>: the advantage of fitness over virulenceNicole Guiso, Benoit Soubeyrand, Denis Macina
Journal of Clinical Microbiology|April 4, 2008
Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?Valérie Caro, Valérie Bouchez, Nicole Guiso
Microbiology (Reading, England)|August 16, 2017
The length of poly(C) stretch in the Bordetella pertussis Pfim3 promoter determines the vag or vrg function of the fim3 geneNao Otsuka, Nicole Guiso, Valérie Bouchez
Expert Review of Anti-Infective Therapy|May 26, 2016
Surveillance of pertussis: methods and implementationNicole Guiso, Carl Heinz Wirsing von König
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Expert Review of Vaccines|July 19, 2014
Other Bordetellas, lessons for and from pertussis vaccinesNicole Guiso, Nicolas Hegerle
Emerging Infectious Diseases|April 30, 2013
Virulence of pertactin-negative Bordetella pertussis isolates from infants, FranceHélène Bodilis, Nicole Guiso
Future Microbiology|November 9, 2013
Epidemiology of whooping cough & typing of Bordetella pertussisNicolas Hegerle, Nicole Guiso
Advances in Experimental Medicine and Biology|July 26, 2019
Pertussis in Low and Medium Income Countries: A Pragmatic ApproachNicole Guiso, Fabien Taieb
Expert Review of Vaccines|June 24, 2014
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccinesNicolas Hegerle, Nicole Guiso
Human Vaccines|March 11, 2011
The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010Nicole Guiso, Johannes Liese, Stanley Plotkin
Evolution, Medicine, and Public Health|August 29, 2022
Can vaccines control bacterial virulence and pathogenicity? <i>Bordetella pertussis</i>: the advantage of fitness over virulenceNicole Guiso, Benoit Soubeyrand, Denis Macina
Journal of Clinical Microbiology|April 4, 2008
Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?Valérie Caro, Valérie Bouchez, Nicole Guiso
Microbiology (Reading, England)|August 16, 2017
The length of poly(C) stretch in the Bordetella pertussis Pfim3 promoter determines the vag or vrg function of the fim3 geneNao Otsuka, Nicole Guiso, Valérie Bouchez
Expert Review of Anti-Infective Therapy|May 26, 2016
Surveillance of pertussis: methods and implementationNicole Guiso, Carl Heinz Wirsing von König
Pageof 13